| Mark E Potter, MD | |
|
22950 Schram Rd, Gretna, NE 68028-4888 | |
| (402) 980-6752 | |
| Not Available |
| Full Name | Mark E Potter |
|---|---|
| Gender | Male |
| Speciality | Pharmacy Technician |
| Location | 22950 Schram Rd, Gretna, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760593255 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Mark E Potter, MD 22950 Schram Rd, Gretna, NE 68028-4888 Ph: (402) 980-6752 | Mark E Potter, MD 22950 Schram Rd, Gretna, NE 68028-4888 Ph: (402) 980-6752 |
News Archive
Merck KGaA, a global pharmaceutical and chemical company, and Millipore Corporation, a leading Life Science company based in Billerica, Massachusetts, USA, today announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore, for US$ 107 per share in cash, or a total transaction value, including net debt, of approximately EUR 5.3 billion (US$ 7.2 billion).
A multi-disciplinary team of Penn researchers, including diabetes, weight loss and bariatric surgery experts, are conducting a study funded by the National Institutes of Health (NIH) to determine if bariatric surgery, either gastric bypass or adjustable gastric banding surgery, is more effective than lifestyle modification to reduce weight and ultimately treat Type 2 diabetes.
As an additional measure in the fight against Zika virus, today the U.S. Food and Drug Administration announced that it has made available a panel of human plasma samples to aid in the regulatory evaluation of serological tests to detect recent Zika virus infection.
On Tuesday, March 29, 2011, hundreds of surgeons from across the country will join together to speak with one voice to their federal legislators. As part of the fourth annual Joint Surgical Advocacy Conference, approximately 70 otolaryngologist-head and neck surgeons representing over 30 states will meet with their U.S. Representatives, Senators, and their staff to encourage Congressional action on several of the specialty's legislative priorities for 2011.
A pioneering clinical trial will investigate the use of cannabidiol (CBD) - a compound found in the cannabis plant - in people with Parkinson's-related psychosis.
› Verified 9 days ago